cas 220812-09-9|| where to buy (3S,4R)-3-amino-4-hydroxy-pyrrolidin-2-one

Nombre del producto:(3S,4R)-3-amino-4-hydroxy-pyrrolidin-2-one

IUPAC Name:(3S,4R)-3-amino-4-hydroxypyrrolidin-2-one

Unidad de embalaje	Stock disponible	Precio($)
CM1018618-100mg	in stock	ŞƥȐ
CM1018618-250mg	in stock	Ǒȯǫ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 220812-09-9 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :220812-09-9; Fórmula molecular:C4H8N2O2; Punto de fusión:-; Código de sonrisas:N[C@@H]1C(=O)NC[C@H]1O; Densidad:

: Número de catálogo:CM1018618; Peso molecular:116.12; Punto de ebullición:; Nº Mdl:; Almacenamiento:

: Pyrrolidines; Pyrrolidine, also known as tetrahydropyrrole, is a saturated five-membered heterocyclic ring, which is miscible with water. Pyrrolidine exists in many alkaloids and drug molecules, such as kappa opioids, antagonists of dopamine D4 receptors, and HIV reverse transcriptase inhibitors.

: VX-147; Vertex Pharmaceuticals announced that inaxaplin (VX-147) , a first-in-class molecule has advanced into the Phase 3 portion of the global Phase 2/3 pivotal clinical trial in APOL1-mediated kidney disease (AMKD), where a 45 mg once daily oral dose will be compared to placebo, on top of standard of care. The clinical trial is designed to assess the impact of inaxaplin on kidney function and proteinuria for people living with proteinuric kidney disease mediated by two variants in the APOL1 gene, known as AMKD. In addition, the trial has been expanded to include adolescents with AMKD ages 10 to 17 years.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.